Advanced search
Publication Cover
Cancer Management and Research Volume 13, 2021 - Issue
Submit an article Journal homepage
81
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Predicting Lymph Node Involvement in Borderline Ovarian Tumors with a Quantitative Model and Nomogram: A Retrospective Cohort Study

Menglei Zhang1 Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, 200011, People’s Republic of China;2 Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Shanghai, 200011, People’s Republic of China
,
Fangyue Zhou1 Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, 200011, People’s Republic of China
,
Yuan He3 Public Health School of Fudan University, Shanghai, 200032, People’s Republic of China
,
Xiang Tao4 Department of Pathology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, 200011, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-1052-118X
ORCID Icon,
Keqin Hua1 Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, 200011, People’s Republic of China;2 Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Shanghai, 200011, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0001-5359-8841
ORCID Icon &
Jingxin Ding1 Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, 200011, People’s Republic of China;2 Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Shanghai, 200011, People’s Republic of ChinaCorrespondence[email protected]
Pages 1529-1539 | Published online: 16 Feb 2021

References

  • Ludovisi M, Foo X, Mainenti S, Testa AC, Arora R, Jurkovic D. Ultrasound diagnosis of serous surface papillary borderline ovarian tumor: a case series with a review of the literature. J Clin Ultrasound. 2015;43(9):573–577. doi:10.1002/jcu.2226625706035
  • Armstrong DK, Alvarez RD. NCCN guidelines version 1.2019 ovarian cancer. Natl Compr Canc Netw. 2019;17(8):896–909. doi:10.6004/jnccn.2019.0039
  • Chen X, Fang C, Zhu T, Zhang P, Yu A, Wang S. Identification of factors that impact recurrence in patients with borderline ovarian tumors. J Ovarian Res. 2017;10:1–8. doi:10.1186/s13048-017-0316-528086946
  • Ureyen I, Karalok A, Tasci T, et al. The factors predicting recurrence in patients with serous borderline ovarian tumor. Int J Gynecol Cancer. 2016;26(1):66–72. doi:10.1097/igc.000000000000056826512785
  • Matsuo K, Machida H, Takiuchi T, et al. Role of hysterectomy and lymphadenectomy in the management of early-stage borderline ovarian tumors. Gynecol Oncol. 2017;144(3):496–502. doi:10.1016/j.ygyno.2017.01.01928131526
  • Shazly SA, Laughlin-Tommaso SK, Dowdy SC, Famuyide AO. Staging for low malignant potential ovarian tumors: a global perspective. Am J Obstet Gynecol. 2016;215(2):153–168.e2. doi:10.1016/j.ajog.2016.04.03527131584
  • Longacre TA, McKenney JK, Tazelaar HD, Kempson RL, Hendrickson MR. Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or =5-year) follow-up. Am J Surg Pathol. 2005;29(6):707–723. doi:10.1097/01.pas.0000164030.82810.db15897738
  • Malpica A, Deavers MT, Gershenson D, Tortolero-Luna G, Silva EG. Serous tumors involving extra-abdominal/extra-pelvic sites after the diagnosis of an ovarian serous neoplasm of low malignant potential. Am J Surg Pathol. 2001;25(8):988–996. doi:10.1097/00000478-200108000-0000211474282
  • Bojana Djordjevic M, Anais Malpica M. Lymph node involvement in ovarian serous tumors of low malignant potential: a clinicopathologic study of thirty-six cases. Am J Surg Pathol. 2010;34(1):1–9. doi:10.1097/PAS.0b013e3181c0a5ab19898226
  • Camatte S, Morice P, Atallah D, et al. Lymph node disorders and prognostic value of nodal involvement in patients treated for a borderline ovarian tumor: an analysis of a series of 42 lymphadenectomies. J Am Coll Surg. 2002;195(3):332–338. doi:10.1016/s1072-7515(02)01250-412229940
  • McKenney JK, Balzer BL, Longacre TA. Lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors): pathology, prognosis, and proposed classification. Am J Surg Pathol. 2006;30(5):614–624. doi:10.1097/01.pas.0000194743.33540.e616699316
  • Leake JF, Rader JS, Woodruff JD, Rosenshein NB. Retroperitoneal lymphatic involvement with epithelial ovarian tumors of low malignant potential. Gynecol Oncol. 1991;42(2):124–130. doi:10.1016/0090-8258(91)90331-x1894170
  • Leake JF, Currie JL, Rosenshein NB, Woodruff JD. Long-term follow-up of serous ovarian tumors of low malignant potential. Gynecol Oncol. 1992;47(2):150–158. doi:10.1016/0090-8258(92)90099-51468692
  • Leung EY, Tirlapur SA, Meads C. The management of secondary lower limb lymphoedema in cancer patients: a systematic review. Palliat Med. 2015;29(2):112–119. doi:10.1177/026921631454580325135888
  • Tamakoshi K, Kikkawa F, Nakashima N, et al. Clinical behavior of borderline ovarian tumors: a study of 150 cases. J Surg Oncol. 1997;64(2):147–152. doi:10.1002/(SICI)1096-9098(199702)64:2<147::AID-JSO11>3.0.CO;2-39047253
  • Cho YH, Kim DY, Kim JH, et al. Is complete surgical staging necessary in patients with stage I mucinous epithelial ovarian tumors? Gynecol Oncol. 2006;103(3):878–882. doi:10.1016/j.ygyno.2006.05.02216859736
  • Moroney MR, Post MD, Berning AA, Sheeder J, Corr BR. An evaluation of frozen section and lymph node dissection results for mucinous ovarian tumors. Int J Gynecol Cancer. 2018;28(1):92–98. doi:10.1097/igc.000000000000115029194190
  • Lesieur B, Kane A, Duvillard P, et al. Prognostic value of lymph node involvement in ovarian serous borderline tumors. Am J Obstet Gynecol. 2011;204(5):438.e1–7. doi:10.1016/j.ajog.2010.12.055
  • Oluwole Fadare M. Recent developments on the significance and pathogenesis of lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors). Int J Gynecol Cancer. 2009;19(1):103–108. doi:10.1111/IGC.0b013e3181991a4919258950
  • Qian XQ, Hua XP, Wu JH, Shen YM, Cheng XD, Wan XY. Clinical predictors of recurrence and prognostic value of lymph node involvement in the serous borderline ovarian tumor. Int J Gynecol Cancer. 2018;28(2):279–284. doi:10.1097/igc.000000000000115429194193

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.